GB201610497D0 - Compound - Google Patents

Compound

Info

Publication number
GB201610497D0
GB201610497D0 GBGB1610497.8A GB201610497A GB201610497D0 GB 201610497 D0 GB201610497 D0 GB 201610497D0 GB 201610497 A GB201610497 A GB 201610497A GB 201610497 D0 GB201610497 D0 GB 201610497D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1610497.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epsilon-3 Bio Ltd And Univ Of Warwick
Original Assignee
Epsilon-3 Bio Ltd And Univ Of Warwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epsilon-3 Bio Ltd And Univ Of Warwick filed Critical Epsilon-3 Bio Ltd And Univ Of Warwick
Priority to GBGB1610497.8A priority Critical patent/GB201610497D0/en
Publication of GB201610497D0 publication Critical patent/GB201610497D0/en
Priority to PCT/GB2017/051767 priority patent/WO2017216579A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB1610497.8A 2016-06-16 2016-06-16 Compound Ceased GB201610497D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1610497.8A GB201610497D0 (en) 2016-06-16 2016-06-16 Compound
PCT/GB2017/051767 WO2017216579A1 (en) 2016-06-16 2017-06-16 Autophagy inducer compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1610497.8A GB201610497D0 (en) 2016-06-16 2016-06-16 Compound

Publications (1)

Publication Number Publication Date
GB201610497D0 true GB201610497D0 (en) 2016-08-03

Family

ID=56895082

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1610497.8A Ceased GB201610497D0 (en) 2016-06-16 2016-06-16 Compound

Country Status (2)

Country Link
GB (1) GB201610497D0 (en)
WO (1) WO2017216579A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4183449A1 (en) 2021-11-17 2023-05-24 Samsara Therapeutics Inc. Autophagy inducing compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101224207A (en) * 2007-10-12 2008-07-23 中国科学院上海有机化学研究所 Medicine for inducing autophagy and treating disease caused by wrong unfolded protein aggregation, and filtration method thereof

Also Published As

Publication number Publication date
WO2017216579A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
GB201602934D0 (en) Compounds
GB201604027D0 (en) Compounds
GB201610854D0 (en) Compounds
GB201604020D0 (en) Compounds
GB201619694D0 (en) Compounds
GB201608777D0 (en) Compounds
HK1255832A1 (en) Pyranodipyridine compound
GB201620119D0 (en) Compounds
GB201521524D0 (en) Compound
RS63143B1 (en) Compounds
GB201604022D0 (en) Compounds
GB201604030D0 (en) Compounds
GB201613946D0 (en) Compounds
GB201617103D0 (en) Compound
GB201612652D0 (en) Novel compound
GB201604029D0 (en) Compounds
GB201622362D0 (en) Compounds
GB201621520D0 (en) Compounds
GB201610497D0 (en) Compound
GB201604031D0 (en) Compounds
GB201518950D0 (en) Compound
HK1251574A1 (en) Tetrahydrooxepinopyridine compound
GB201619531D0 (en) Compound
GB201619526D0 (en) Compound
GB201613035D0 (en) Compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)